Cravatex (CRAVATEX)₹336.60−2.09%Trading & Distributors
In the Jun 2026 quarter (consolidated), Cravatex reported sales of ₹32.27 Cr, up 39.3% from Jun 2025, and net profit of ₹0.43 Cr. For the year to Mar 2026, sales were ₹151 Cr and net profit ₹6.99 Cr.
Company filings, consolidated accounts; latest reported quarter Jun 2026
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 57.52 | 37.98 | 50.74 | 25.82 | 55.15 | 32.46 | 60.65 | 23.17 | 51.54 | 36.83 | 39.60 | 32.27 |
| Expenses | 59.72 | 41.73 | 52.61 | 28.14 | 53.07 | 34.35 | 60.06 | 29.28 | 48.74 | 39.29 | 40.17 | 35.54 |
| Operating Profit | −2.16 | −3.78 | −1.87 | −2.32 | 2.00 | −1.86 | 0.50 | −6.10 | 2.74 | −2.43 | −0.58 | −3.26 |
| OPM % | −3.8% | −10.0% | −3.7% | −9.0% | 3.7% | −5.8% | 0.8% | −26.4% | 5.4% | −6.6% | −1.5% | −10.1% |
| Other Income | 6.02 | 5.81 | 2.67 | 3.47 | 2.13 | 2.23 | 2.08 | 5.20 | 3.79 | 4.51 | 3.29 | 4.39 |
| Interest | 0.07 | 0.14 | 0.12 | 0.12 | 0.12 | 0.12 | 0.10 | 0.10 | 0.08 | 0.08 | 0.08 | 0.07 |
| Depreciation | 0.54 | 0.50 | 0.40 | 0.35 | 0.35 | 0.41 | 0.41 | 0.39 | 0.39 | 0.39 | 0.38 | 0.39 |
| Profit before tax | 3.24 | 1.40 | 0.29 | 0.69 | 3.69 | −0.13 | 2.10 | −1.36 | 6.07 | 1.60 | 2.24 | 0.66 |
| Tax % | 4.0% | 44.0% | −70.0% | 30.0% | 28.4% | −278.6% | 31.8% | 0.7% | 14.3% | 16.8% | 28.4% | 34.3% |
| Net Profit | 3.10 | 0.78 | 0.49 | 0.47 | 2.64 | 0.24 | 1.43 | −1.36 | 5.21 | 1.34 | 1.59 | 0.43 |
| EPS (Rs) | 12.05 | 3.07 | 1.94 | 1.87 | 10.27 | 0.98 | 5.58 | −5.31 | 20.24 | 5.23 | 6.21 | 1.71 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 255 | 266 | 357 | 720 | 866 | 533 | 595 | 505 | 203 | 174 | 151 | 160 |
| Expenses | 249 | 271 | 361 | 694 | 845 | 543 | 593 | 534 | 210 | 175 | 157 | 164 |
| Operating Profit | 5.99 | −4.99 | −5.99 | 23.95 | 20.95 | −10.98 | 1.99 | −29.96 | −7.98 | −1.99 | −5.99 | −3.53 |
| OPM % | 2.3% | −1.7% | −1.6% | 3.4% | 2.5% | −2.1% | 0.4% | −6.0% | −3.8% | −1.0% | −4.2% | −2.2% |
| Other Income | 2.99 | 3.99 | 3.99 | 3.99 | 4.99 | 12.98 | 9.98 | 118 | 15.97 | 9.98 | 16.96 | 15.98 |
| Interest | 12.99 | 11.01 | 4.99 | 5.99 | 14.01 | 15.01 | 14.01 | 14.01 | 0.00 | 0.00 | 0.00 | 0.31 |
| Depreciation | 3.01 | 3.01 | 6.01 | 6.01 | 15.02 | 17.03 | 16.03 | 16.03 | 2.01 | 1.01 | 2.01 | 1.55 |
| Profit before tax | −6.98 | −14.97 | −11.97 | 16.95 | −1.99 | −29.92 | −18.95 | 57.86 | 5.99 | 5.98 | 8.97 | 10.57 |
| Tax % | 8.0% | −9.0% | 2.0% | 37.0% | 95.0% | 3.0% | 7.0% | −1.0% | 22.0% | 24.0% | 21.0% | — |
| Exceptional items | 0.00 | 0.00 | 0.44 | 0.09 | 0.00 | −0.46 | 0.13 | 104 | 0.01 | 0.02 | 0.07 | — |
| Net Profit | −7.99 | −13.97 | −11.97 | 10.98 | −4.99 | −30.94 | −19.98 | 58.94 | 4.99 | 4.99 | 6.99 | 8.57 |
| EPS (Rs) | −30.73 | −53.79 | −47.83 | 41.32 | −18.26 | −118.69 | −77.14 | 228.59 | 18.72 | 18.72 | 26.38 | 33.39 |
| Dividend payout % | 0.0% | 0.0% | −2.0% | 5.0% | −16.0% | −3.0% | −4.0% | 1.0% | 16.0% | 67.0% | 49.0% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 2.99 | 2.99 | 2.99 | 2.99 | 2.99 | 2.99 | 2.99 | 2.99 | 2.99 | 2.99 | 2.99 | 2.99 |
| Reserves | 41.00 | 33.02 | 18.98 | 7.00 | 17.02 | −4.01 | −31.05 | −52.11 | 90.06 | 95.88 | 104 | 117 |
| Borrowings | 66.09 | 72.04 | 135 | 105 | 117 | 203 | 155 | 167 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Liabilities | 53.73 | 66.68 | 62.69 | 93.55 | 162 | 240 | 258 | 246 | 43.79 | 25.87 | 33.84 | 26.87 |
| Total Liabilities | 164 | 175 | 220 | 208 | 298 | 441 | 384 | 364 | 137 | 125 | 141 | 146 |
| Fixed Assets | 28.95 | 27.95 | 52.94 | 47.95 | 47.94 | 91.80 | 75.93 | 61.92 | 7.99 | 8.99 | 8.98 | 7.99 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 6.02 | 1.01 | 25.10 | 15.04 | 5.02 | 5.02 | 8.02 | 16.06 | 19.08 |
| Other Assets | 135 | 147 | 167 | 155 | 249 | 324 | 293 | 298 | 124 | 108 | 116 | 119 |
| Inventories | 48.95 | 55.96 | 41.96 | 35.99 | 83.90 | 81.93 | 84.89 | 93.91 | 28.97 | 10.99 | 11.01 | 22.98 |
| Trade receivables | 73.24 | 74.23 | 61.22 | 103 | 151 | 170 | 143 | 134 | 26.07 | 14.05 | 24.09 | 16.05 |
| Cash & equivalents | 4.01 | 8.02 | 57.16 | 7.02 | 5.01 | 49.15 | 36.12 | 38.09 | 56.19 | 76.19 | 75.26 | 77.24 |
| Total Assets | 164 | 175 | 220 | 208 | 298 | 441 | 384 | 364 | 137 | 125 | 141 | 146 |
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 34.99 | −13.01 | −4.99 | 32.01 | −4.01 | −8.01 | 144 | 19.01 | 3.01 | 1.01 |
| Cash from investing activity | −24.06 | −4.01 | 3.01 | −37.13 | 21.05 | 14.04 | 42.10 | −1.01 | −1.01 | 3.01 |
| Cash from financing activity | 37.90 | −33.90 | 0.00 | 36.90 | −20.94 | −3.99 | −168 | 0.00 | −0.99 | −2.99 |
| Net cash flow | 50.13 | −51.15 | −2.01 | 32.11 | −4.01 | 3.01 | 18.07 | 17.06 | 2.01 | 1.01 |
| Capex | 21.96 | 0.61 | 5.79 | 8.12 | 2.69 | 1.72 | 0.00 | 1.02 | 1.79 | 0.41 |
| Free cash flow | 13.05 | −13.05 | −10.03 | 24.08 | −6.02 | −9.03 | 183 | 18.07 | 1.01 | 1.01 |
| CFO / OP % | −779.1% | 188.0% | −10.1% | 163.0% | 25.0% | −300.0% | −485.0% | −274.0% | −245.0% | −48.1% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 114 | 105 | 83 | 105 | 75 | 71 | 97 | 81 | 18 | 24 | 49 | 39 |
| Inventory days | 123 | 123 | 83 | 52 | 59 | 48 | 84 | 83 | 28 | 27 | 39 | 110 |
| Days payable | 66 | 71 | 65 | 89 | 16 | 25 | 23 | 36 | 21 | 25 | 43 | 39 |
| Cash conversion cycle | 172 | 158 | 101 | 69 | 119 | 94 | 159 | 129 | 26 | 27 | 46 | 110 |
| Working capital days | 42 | 20 | −4 | 40 | 27 | 10 | 24 | 29 | 16 | 15 | 19 | 43 |
| ROCE % | 11.9% | 5.0% | −3.0% | −6.0% | 17.9% | 6.0% | −6.1% | −2.0% | −24.1% | 6.9% | 6.9% | 8.0% |
For the Jun 2026 quarter, Cravatex reported sales of ₹32.27 Cr, up 39.3% year on year and net profit of ₹0.43 Cr. The operating margin was −10.1%.
Cravatex's sales for the year to Mar 2026 were ₹151 Cr; over the last twelve months they were ₹160 Cr.
Net profit for the year to Mar 2026 was ₹6.99 Cr, and ₹8.57 Cr over the last twelve months. Earnings per share over the same trailing period were ₹33.39.
Cravatex reported borrowings of ₹0 Cr at Mar 2026, against cash and equivalents of ₹77.24 Cr.
Cash from operations was ₹1.01 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹1.01 Cr.